EXICURE, INC. (XCUR)

↓ Download CSV

CIK 0001698530 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, EXICURE, INC. reported revenue of $0, down 100.0% from the prior year. The company ran a net loss. It held $14.04M in total assets against $10.12M in total liabilities.

Key ratios (FY2025)

-126.0%
Return on equity
-100.0%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$0$500.0K$0$28.83M-$483.0K$16.61M$1.30M$118.0K$9.72M$1.04M
Operating Income-$4.23M-$12.23M-$15.00M-$1.83M-$62.55M-$25.44M-$26.62M-$21.82M-$10.41M-$16.16M
Net Income-$4.95M-$9.70M-$16.91M-$2.58M-$64.10M-$24.67M-$26.30M-$22.41M-$11.01M-$16.94M
EPS (Diluted)$-0.79$-4.75$-10.55$-0.56$-21.70$-0.28
Total Assets$14.04M$15.06M$11.58M$23.33M$64.87M$100.44M$115.26M$28.76M$28.99M$20.58M
Total Liabilities$10.12M$8.28M$8.55M$8.41M$53.64M$38.94M$34.52M$7.80M$9.01M$18.13M
Shareholders' Equity$3.93M$6.77M$3.03M$14.92M$11.23M$61.51M$80.75M$20.95M$19.98M$2.45M
Cash & Equivalents$816.0K$8.58M$34.64M$33.26M$48.46M$26.27M$25.76M$19.62M
Operating Cash Flow-$8.55M-$2.91M-$10.36M-$35.66M-$34.82M-$39.27M$1.32M-$19.49M-$19.79M-$5.05M
Capital Expenditures$1.0K$0$0$10.0K$968.0K$3.17M$1.08M$94.0K$926.0K$394.0K
Shares Outstanding6.37M6.03M1.83M4.97M3.63M87.65M86.07M44.36M39.30M131.6K